CMS rejects guidance call on autoimmune treatments

Original Article by Tamar Kahn | Business Day | 19 September 2024

The CMS has rejected the Autoimmune Alliance of SA's request for clear guidance on biologic treatment funding, stating cases must be assessed individually.

The CMS has rejected the Autoimmune Alliance of SA’s request for clear guidance on biologic treatment funding, stating cases must be assessed individually.

Subscription Required

You must be a subscriber to access all of this content.

View Subscriptions

Already a subscriber? Log in here

More Posts

Compounded semaglutide appeal dismissed

A court has upheld restrictions on compounded semaglutide at iDexis while regulatory investigations continue.

Read more...

WHO’s Africa Chief Urges Action, Not Talk, on Primary Healthcare

WHO Africa director Mohamed Janabi urged governments to finance primary healthcare and pursue health sovereignty.

Read more...

Unpaid specialist training strains SA doctors

Unpaid specialist training is growing in South Africa as scarce funded posts leave doctors working without salaries.

Read more...